Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,168.2 | 150.38 | 1,13,590.5 | 177.39 | 0.13 | 658.7 | 85.26 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,942.5 | 76.99 | 99,811 | 333.4 | 0.4 | 2,075.3 | 607.44 |
Fortis Healthcare Ltd FORTIS | 763.3 | 449.24 | 57,656.15 | -42.23 | 0.13 | 388.47 | 120.19 |
Narayana Hrudayalaya Ltd NH | 1,750.7 | 83.09 | 35,828.54 | 159.98 | 0.26 | 919.03 | 106.95 |
Global Health Ltd MEDANTA | 1,216.1 | 65.54 | 32,669.63 | 93.41 | 0 | 802.87 | 130.22 |
The purchase is anticipated to enhance Syngene's position in the biologics contract development and manufacturing organization (CDMO) arena, specifically in the US market.
The company reported an operating EBITDA of ₹343.60 Crore in the quarter four of FY25. It registered a growth of 8.4% on a year-on-year basis.
This acquisition will also augment Syngene’s biologics capabilities and further strengthen its global presence.
The company's revenue from operations also grew healthily, up by 10.6% YoY to ₹943 crore, as against ₹853.5 crore in Q3 FY24.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
